Comparison · NCT03532932-41b66ff1
UC Participants vs CD Participants: Number of Participants With at Least One Episode of Failure of Biological or Non-biological Therapy
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. UC Participants vs CD Participants: Number of Participants With at Least One Episode of Failure of Biological or Non-biological Therapy. Trial comparisons, record NCT03532932-41b66ff1. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03532932-41b66ff1
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.991 | 0.984 | 0.995 | wilson | |
| Risk in group 2 | 0.975 | 0.961 | 0.984 | wilson | |
| Risk difference, group 1 minus group 2 | 0.0157 | 0.00404 | 0.0307 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.02 | 1 | 1.03 | log | |
| Odds ratio, group 1 over group 2 | 2.77 | 1.29 | 5.96 | log | |
| Number needed to treat, for one more participant with the outcome on UC Participants than on CD Participants | 63.8 | 32.5 | 248 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | UC Participants | Participants diagnosed with moderate to severe UC were observed retrospectively for previous 2 years before enrollment until Baseline Visit 1 (Day 1) and further observed prospectively for 1 year after participants were enrolled into the study during Observational Visit 2 at 6 months and Final Visit 3 at 12 months to assess treatment patterns and treatment outcomes. | 1,203 | 1,214 | OG000 |
| Group 2 | CD Participants | Participants diagnosed with moderate to severe CD were observed retrospectively for previous 2 years before enrollment until Baseline Visit 1 (Day 1) and further observed prospectively for 1 year after participants were enrolled into the study during Observational Visit 2 at 6 months and Final Visit 3 at 12 months to assess treatment patterns and treatment outcomes. | 670 | 687 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Participants With at Least One Episode of Failure of Biological or Non-biological Therapy
- Description
- Time frame
- From 2 years before enrollment up to Month 12 after enrollment (up to 3 years)
- Population
- FAS included those participants who signed the informed consent form and were analyzed in the study.
Source ClinicalTrials.gov
Trial
- Title
- A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice
- NCT number
- NCT03532932
- Phases
- Conditions
- Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases
- Interventions
- Lead sponsor
- Takeda
- Results first posted
- 2024-03-29
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT03532932?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT03532932-41b66ff1